News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Louis P. Garrison Jr, PhD

Articles by Louis P. Garrison Jr, PhD

AJMC

Challenges With Judging and Interpreting a Drug’s Launch Price

ByMelanie D. Whittington, PhD,Louis P. Garrison Jr, PhD,Jonathan D. Campbell, PhD, MS

March 24th 2025

This commentary explains why comparing a launch price with a value-based price from a cost-effectiveness analysis requires further examination.

Private Sector Risk-Sharing Agreements in the United States: Trends, Barriers, and Prospects

ByLouis P. Garrison Jr, PhD,Josh J. Carlson, PhD,Preeti S. Bajaj, PhD,Adrian Towse, MA, MPhil,Peter J. Neumann, ScD,Sean D. Sullivan, PhD,Kimberly Westrich, MA,Robert W. Dubois, MD, PhD

September 15th 2015

Assessment of current trends, success factors, and challenges in the use of risk-sharing agreements in the US private sector.

Toward Evidence-based Assessment for Coverage and Reimbursement of Laboratory-based Diagnostic and Genetic Tests

ByScott D. Ramsey, MD, PhD,David L. Veenstra, PharmD, PhD,Louis P. Garrison Jr, PhD,Rick Carlson, JD,Paul Billings, MD, PhD,Josh Carlson, MS,Sean D. Sullivan, PhD

April 1st 2006

Latest Updated Articles

Challenges With Judging and Interpreting a Drug’s Launch Price
March 24th 2025
Private Sector Risk-Sharing Agreements in the United States: Trends, Barriers, and Prospects
September 15th 2015
Toward Evidence-based Assessment for Coverage and Reimbursement of Laboratory-based Diagnostic and Genetic Tests
April 1st 2006

Trending on AJMC

Judge Denies Preliminary Injunction in Medicaid Work Requirements Case

AHRQ Grant Freeze Halts Patient Safety Research Nationwide

FDA Advisory Panel Votes Against Approval of Deramiocel for DMD

MASLD, MASH Linked to Higher Mild Cognitive Impairment Risk, Lower Dementia Odds

The Future of RRFL: Personalized Treatment, Novel Agents, and Moving Beyond Chemotherapy